This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Jul 15;363(3):285-6.

doi: 10.1056/NEJMe1004992.

Rituximab in ANCA-associated disease

Ronald J Falk, J Charles Jennette

PMID: 20647204
DOI: 10.1056/NEJMe1004992

Editorial

Rituximab in ANCA-associated disease

Ronald J Falk et al. N Engl J Med. 2010.

. 2010 Jul 15;363(3):285-6.

doi: 10.1056/NEJMe1004992.

Authors

Ronald J Falk, J Charles Jennette

PMID: 20647204
DOI: 10.1056/NEJMe1004992

Erratum in

N Engl J Med. 2010 Aug 19;363(8):798

No abstract available

PubMed Disclaimer

Comment on

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh D, Walsh M, Westman K, Jayne DR; European Vasculitis Study Group. Jones RB, et al. N Engl J Med. 2010 Jul 15;363(3):211-20. doi: 10.1056/NEJMoa0909169. N Engl J Med. 2010. PMID: 20647198 Clinical Trial.
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group. Stone JH, et al. N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905. N Engl J Med. 2010. PMID: 20647199 Free PMC article. Clinical Trial.

Similar articles

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh D, Walsh M, Westman K, Jayne DR; European Vasculitis Study Group. Jones RB, et al. N Engl J Med. 2010 Jul 15;363(3):211-20. doi: 10.1056/NEJMoa0909169. N Engl J Med. 2010. PMID: 20647198 Clinical Trial.
S2. Rituximab for ANCA-associated vasculitis: the UK experience.
Jayne D. Jayne D. Presse Med. 2013 Apr;42(4 Pt 2):532-4. doi: 10.1016/j.lpm.2013.01.049. Epub 2013 Mar 9. Presse Med. 2013. PMID: 23490639 Review. No abstract available.
[Rituximab for the treatment of ANCA associated vasculitis: the future today?].
Alba MA, Flores-Suárez LF. Alba MA, et al. Reumatol Clin. 2011 Dec;7 Suppl 3:S41-6. doi: 10.1016/j.reuma.2011.10.006. Epub 2011 Nov 23. Reumatol Clin. 2011. PMID: 22115869 Review. Spanish.
[The role of rituximab in the treatment of ANCA-associated systemic vasculitis].
Roccatello D, Vangelista A, Pani A. Roccatello D, et al. G Ital Nefrol. 2011 Sep-Oct;28(5):474-88. G Ital Nefrol. 2011. PMID: 22028261 Review. Italian.
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D, Luqmani R, Mills J, Mooney J, Venning M, Watts RA; BSR and BHPR Standards, Guidelines and Audit Working Group. Ntatsaki E, et al. Rheumatology (Oxford). 2014 Dec;53(12):2306-9. doi: 10.1093/rheumatology/ket445. Epub 2014 Apr 11. Rheumatology (Oxford). 2014. PMID: 24729399 No abstract available.

See all similar articles

Cited by

Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission.
Muto R, Inagaki K, Sato N, Sameshima T, Nagakura Y, Baba S, Kato N, Maruyama S, Akahori T. Muto R, et al. Intern Med. 2020 Dec 15;59(24):3187-3193. doi: 10.2169/internalmedicine.4731-20. Epub 2020 Aug 12. Intern Med. 2020. PMID: 32788533 Free PMC article.
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
Jennette JC, Falk RJ, Hu P, Xiao H. Jennette JC, et al. Annu Rev Pathol. 2013 Jan 24;8:139-60. doi: 10.1146/annurev-pathol-011811-132453. Annu Rev Pathol. 2013. PMID: 23347350 Free PMC article. Review.
Progressive dyspnoea following the treatment of Mycobacterium abscessus infection in an individual with relapsing granulamatosis with polyangitis (Wegener's), complicated by hearing loss requiring cochlear implantation.
Tagboto SK, Venkatesh AG. Tagboto SK, et al. BMC Pulm Med. 2012 Sep 4;12:47. doi: 10.1186/1471-2466-12-47. BMC Pulm Med. 2012. PMID: 22947057 Free PMC article. Review.
Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.
Latimer NR, Carroll C, Wong R, Tappenden P, Venning MC, Luqmani R. Latimer NR, et al. Pharmacoeconomics. 2014 Dec;32(12):1171-83. doi: 10.1007/s40273-014-0189-z. Pharmacoeconomics. 2014. PMID: 25059204 Free PMC article.
Biologic agents in systemic vasculitis.
Henderson CF, Seo P. Henderson CF, et al. Int J Clin Rheumtol. 2011;6(4):453-462. doi: 10.2217/IJR.11.29. Int J Clin Rheumtol. 2011. PMID: 23785387 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.